高级搜索

LIMK1在结肠癌组织中表达的临床病理意义

颜鸿飞, 苏坚, 廖前进, 史玲, 杨晶, 苏琦

颜鸿飞, 苏坚, 廖前进, 史玲, 杨晶, 苏琦. LIMK1在结肠癌组织中表达的临床病理意义[J]. 肿瘤防治研究, 2013, 40(06): 576-579. DOI: 10.3971/j.issn.1000-8578.2013.06.017
引用本文: 颜鸿飞, 苏坚, 廖前进, 史玲, 杨晶, 苏琦. LIMK1在结肠癌组织中表达的临床病理意义[J]. 肿瘤防治研究, 2013, 40(06): 576-579. DOI: 10.3971/j.issn.1000-8578.2013.06.017
YAN Hongfei, SU Jian, LIAO Qianjin, SHI Ling, YANG Jing, SU Qi. Clinicopathologic Significance of LIMK1 Expression in Human Colon Cancer[J]. Cancer Research on Prevention and Treatment, 2013, 40(06): 576-579. DOI: 10.3971/j.issn.1000-8578.2013.06.017
Citation: YAN Hongfei, SU Jian, LIAO Qianjin, SHI Ling, YANG Jing, SU Qi. Clinicopathologic Significance of LIMK1 Expression in Human Colon Cancer[J]. Cancer Research on Prevention and Treatment, 2013, 40(06): 576-579. DOI: 10.3971/j.issn.1000-8578.2013.06.017

LIMK1在结肠癌组织中表达的临床病理意义

基金项目: 国家自然科学基金资助项目(31000629);湖南省卫生厅科研项目(B2008-067)
详细信息
    作者简介:

    颜鸿飞(1969-),女,硕士,副主任医师,主要从事消化道肿瘤的研究

    通讯作者:

    苏琦,E-mail: suqi1945@yahoo.com.cn

  • 中图分类号: R735.3

Clinicopathologic Significance of LIMK1 Expression in Human Colon Cancer

  • 摘要: 目的 研究LIMK1表达与结肠癌发生、分化程度、肿瘤大小、淋巴结转移、临床分期的关系。 方法 将87例结肠癌、26例腺瘤及34例正常结肠组织共147例结肠标本制成组织芯片,采用免疫组织化学技术检测结肠癌、腺瘤及正常组织中LIMK1表达。 结果 LIMK1在腺癌组织中表达[75.86% (66/87)]明显高于在腺瘤[38.46% (10/26)]与结肠正常黏膜[20.58%(7/34)]组织中的表达(P<0.05),而腺瘤组织中的表达高于正常黏膜组织(P<0.05)。高分化结肠癌组织中LIMK1表达率[40.00% (4/10)]明显高于中分化结肠癌组织中的表达率[70.21%(33/47)]与低分化腺癌结肠癌组织中的表达率[96.67% (29/30)](P<0.05),而中分化结肠癌组织中的表达率显著高于低分化腺癌(P<0.05)。体积<5.0 cm结肠癌组织LIMK1表达[57.14%(20/35)]明显低于≥5.0 cm的表达[88.46%(46/52)](P<0.05)。淋巴结转移表达97.78%(44/45)显著高于无淋巴结转移的表达[52.38% (22/42)](P<0.05)。Dukes分期A+B组LIMK1表达[ 60.98%(25/41)]明显低于C+D组[89.13%(41/46)](P<0.05)。 结论 LIMK1表达与结肠癌的发生、分化程度、肿瘤大小、淋巴结转移、临床分期密切相关,其可能是结肠癌侵袭转移的重要标志。

     

    Abstract: Objective To investigate the relations between LIMK1 expression and carcinogenesis, tumor size, pathological classification, lymph node metastasis and clinical stages in human colon cancer. Methods Immunohistochemistry method using tissue chip was used to examine the expression of LIMK1 in colon cancer (87 cases), adenoma (26 cases) and normal tissue (34 cases). Results The expression level of LIMK1 in colon cancer was 75.86% (66/87),and significantly higher than 20.58% (7/34) in normal tissue and 38.46% (10/26) in adenoma, respectively.LIMK1 in adenoma was significantly higher than that in the normal tissue (P<0.05). LIMK1 expression in well-differentiated was 40.00% (4/10) and lower than 70.21% (33/47) in moderately differentiated and 96.67% (29/30) in poorly differentiated adenocarcinoma, LIMK1 expression in moderately differentiated was lower than that in poorly differentiated adenocarcinoma (P<0.05). The expression of LIMK1 in volume<5.0 cm of colon cancer was lower than that in volume ≥5.0 cm,57.14%(20/35) vs.88.46% (46/52) (P<0.05). The expression of LIMK1 of lymph node metastasis was increased compared with non-lymph nale metastasis 97.78% (44/45) vs.52.38% (22/42) (P<0.05). The expression of LIMK1 in Dukes stage A and B was significantly lower than in C and D 60.98% (25/41) vs.89.13% (41/46) (P<0.05). There was no significantly correlation between age and the expression of LIMK1 (P>0.05). Conclusion The expression of LIMK1 is closely related to carcinogenesis, tumor size, pathological classification, lymph node metastasis and clinical stage in colon cancer, suggesting that LIMK1 may be a important biomarker of invasion and metastasis.

     

  • [1] Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CA Cancer J Clin, 2011,61(2):69-90.
    [2] Ma YH, Shi L, Su Q. LIM kinase and tumor [J]. Guo Ji Bing Li Ke Xue Yu Lin Chuang Za Zhi, 2009, 29(6): 490-3. [马艳华, 史玲, 苏琦. LIM激酶与肿瘤[J]. 国际病理科学与临床杂志, 2009, 29(6): 490-3.]
    [3] Davila M, Frost AR, Grizzle WE, et al. LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer[J]. J Biol Chem, 2003, 278(38): 36868-75.
    [4] Bagheri-Yarmand R, Mazumdar A, Sahin AA, et al. LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system [J]. Int J Cancer, 2006, 118(11): 2703-10.
    [5] Chhavi, Saxena M, Singh S, et al. Expression profiling of G2/M phase regulatory proteins in normal, premalignant and malignant uterine cervix and their correlation with survival of patients [J]. J Cancer Res Ther, 2010,6(2):167-71.
    [6] Wu YJ, Tang Y, Li Z, et al. Clinicopathological significance of expression of LIMK1 in gastric cancer [J]. Lin Chuang Yu Shi Yan Bing Li Xue Za Zhi, 2011, 27(6): 658-60.[吴勇军, 唐仪, 李筝, 等. 胃癌中LIMK1的表达及其病理意义[J]. 临床与实验病理学杂志, 2011,27(6): 658-60. ]
    [7] Xu X, Johnson P, Mueller SC. Breast cancer cell movement: imaging invadopodia by TIRF and IRM microscopy [J]. Methods Mol Biol, 2009, 571: 209-25.
    [8] Yang C, Czech L, Gerboth S, et al. Novel roles of formin mDia2 in lamellipodia and filopodia formation in motile cells [J]. PLoS Biol, 2007, 5(11): e317.
    [9] Nishita M, Tomizawa C, Yamamoto M, et al. Spatial and temporal regulation of cofilin activity by LIM kinase and Slingshot is critical for directional cell migration [J]. J Cell Biol, 2005,171(2):349-59.
    [10] Soosairajah J, Maiti S, Wiggan O, et al. Interplay between components of a novel LIM kinase-slingshot phosphatase complex regulates cofilin [J]. EMBO J, 2005, 24(3): 473-86.
    [11] Lee YJ, Mazzatti DJ, Yun Z, et al. Inhibition of invasiveness of human lung cancer cell line H1299 by over-expression of cofilin [J]. Cell Biol Int, 2005, 29(11): 877-83.
    [12] Guo H, Gu F, Li W, et al. Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells [J]. J Neurochem, 2009, 109(1): 203-13.
    [13] McConnell BV, Koto K, Gutierrez-Hartmann A. Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression [J]. Mol Cancer,2011,10:75.
    [14] Shi L, Su J, Liao QJ, et al. Diallyl disulfide inhibits migration and invasion in human Colon cancer SW480 cells by downregulating expression of LIMK1[J]. Zhongguo Yao Li Xue Tong Bao, 2011,27(2): 200-5.[史玲, 苏坚, 廖前进, 等. 二烯丙基二硫下调LIMK1抑制人结肠癌SW480细胞迁移与侵袭[J]. 中国药理学通报, 2011, 27(2): 200-5.]
计量
  • 文章访问数:  2167
  • HTML全文浏览量:  20
  • PDF下载量:  327
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-07-01
  • 修回日期:  2012-08-23
  • 刊出日期:  2013-06-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭